National Cholesterol Education Program (NCEP)- Adult Treatment Panel (ATP III) guidelines

Adult Treatment Panel (ATP) III Analysis

This program will calculate not only the Framingham 10-year risk percentage but also will provide treatment guidelines based on the latest clinical data.

Age:    Sex:       SBP: mmHg
Total cholesterol:mg/dl     HDL: mg/dl      LDL:
Triglyceride level:      Taking medication for blood pressure?

Are any of the following present ? (review factors under 1, and 2)
1) Clinical coronary heart disease (CHD): Includes history of :
a) myocardial infarction,
b) unstable angina or stable angina,
c) coronary artery procedures (angioplasty or bypass surgery), or
d) evidence of clinically significant myocardial ischemia.

2) CHD Risk equivalents: includes clinical manifestations of noncoronary forms of atherosclerotic disease:
a) peripheral arterial disease,
b) abdominal aortic aneurysm,
c) carotid artery disease (transient ischemic attacks or stroke of carotid origin or >50%
obstruction of a carotid artery),
d) diabetes ,
e) 2 risk factors with 10-year risk for hard CHD >20%.

How many of the following risk factors are present if any? (Note: if HDL

60, subtract one from the total count).
1) Cigarette smoking
2) Hypertension (BP

140/90 mmHg or on antihypertensive medication)
3) Low HDL cholesterol (<40 mg/dL)
4) Family history of premature CHD (CHD in male first degree relative <55 years; CHD in female first degree relative <65 years).
5) Age (men

45 years; women

55 years)

Metabolic Syndrome – Are at least 3 of the following present after 3 months of therapeutic lifestyle changes?

1) Abdominal obesity (Waist circumference)
Men: >102 cm (>40 in)
Women: >88 cm (>35 in)
2.) Triglycerides

150 mg/dL

3.) HDL cholesterol
Men: <40 mg/dL
Women: <50 mg/dL
4.) Blood pressure:

130/

85 mmHg
5.) Fasting glucose:

110 mg/dL